Madhvi Patel, MD
Family Medicine · Rocky Mount, NCNPI 1912160995
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations.
Across 23 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$125
- Cequr Corporation$109
- Boehringer Ingelheim$103
- AbbVie$93
- Paratek Pharmaceuticals, Inc.$47
- Teleflex LLC$44
- plus $133 from 5 others
Across 5 payments — averaging $5241.60 each. An ownership or investment interest held by the physician or an immediate family member.
- The North Carolina Mutual Wholesale Drug Company Inc$26K
What the payments were for
- Food & beverage$653100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 1 | $125 |
| Cequr Corporation | 1 | $109 |
| Boehringer Ingelheim | 5 | $103 |
| AbbVie | 4 | $93 |
| Paratek Pharmaceuticals, Inc. | 3 | $47 |
| Teleflex LLC | 2 | $44 |
| AstraZeneca(2 entities) | 2 | $37 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Bioxcel Therapeutics, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Abbott | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$125
- CeQur Simplicity$109
How this compares
$653 in reported general payments places this provider in the 60th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 52 | $382 |
| Cefdinir | 24 | $244 |
| Furosemide | 37 | $210 |
| Atorvastatin Calcium | 36 | $202 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 40 | $198 |
| Metoprolol Succinate | 25 | $158 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $125 |
| Pantoprazole Sodium | 18 | $104 |
| Methylprednisolone | 14 | $103 |
| ClopidogrelClopidogrel Bisulfate | 16 | $77 |
| Losartan Potassium | 17 | $74 |
| Doxycycline Hyclate | 17 | $69 |
| Carvedilol | 11 | $60 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rocky Mount
- Richard MichalRocky Mount$97K
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.